Proteinase K Market Size, Share & Trends Analysis Report By Form (Powder, Liquid), By Therapeutic Area (Infectious Diseases, Neurology, Oncology, Cardiology), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                        1.1.1. Form
                        1.1.2. Therapeutic area
                        1.1.3. End use
                        1.1.4. Application
                        1.1.5. Regional scope
                        1.1.6. Estimates and forecast timeline
                    1.2. Research Methodology
                    1.3. Information Procurement
                        1.3.1. Purchased database
                        1.3.2. GVR’s internal database
                        1.3.3. Secondary sources
                        1.3.4. Primary research
                        1.3.5. Details of primary research
                    1.4. Information or Data Analysis
                    1.5. Market Formulation & Validation
                    1.6. Model Details
                    1.7. List of Secondary Sources
                    1.8. List of Primary Sources
                    1.9. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Form outlook
                        2.2.2. Therapeutic area outlook
                        2.2.3. End use outlook
                        2.2.4. Application outlook
                        2.2.5. Regional outlook
                    2.3. Competitive Insights
Chapter 3. Proteinase K Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Penetration & Growth Prospect Mapping
                    3.3. Market Dynamics
                        3.3.1. Market driver analysis
                        3.3.2. Market restraint analysis
                    3.4. Proteinase K Market Analysis Tools
                        3.4.1. Industry Analysis - Porter’s
                            3.4.1.1. Supplier power
                            3.4.1.2. Buyer power
                            3.4.1.3. Substitution threat
                            3.4.1.4. Threat of new entrant
                            3.4.1.5. Competitive rivalry
                        3.4.2. PESTEL Analysis
                            3.4.2.1. Political landscape
                            3.4.2.2. Technological landscape
                            3.4.2.3. Economic landscape
Chapter 4. Proteinase K: Form Estimates & Trend Analysis
                    4.1. Proteinase K Market: Key Takeaways
                    4.2. Proteinase K Market: Movement & Market Share Analysis, 2022 & 2030
                    4.3. Powder
                        4.3.1. Powder market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.4. Liquid
                        4.4.1. Liquid market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Proteinase K: Therapeutic Area Estimates & Trend Analysis
                    5.1. Proteinase K Market: Key Takeaways
                    5.2. Proteinase K Market: Movement & Market Share Analysis, 2022 & 2030
                    5.3. Infectious Diseases
                        5.3.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
                    5.4. Diabetes
                        5.4.1. Diabetes market estimates and forecasts, 2018 to 2030 (USD Million)
                    5.5. Oncology
                        5.5.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
                    5.6. Cardiology
                        5.6.1. Cardiology market estimates and forecasts, 2018 to 2030 (USD Million)
                    5.7. Nephrology
                        5.7.1. Nephrology market estimates and forecasts, 2018 to 2030 (USD Million)
                    5.8. Autoimmune Diseases
                        5.8.1. Autoimmune diseases market estimates and forecasts, 2018 to 2030 (USD Million)
                    5.9. Neurology
                        5.9.1. Neurology market estimates and forecasts, 2018 to 2030 (USD Million)
                    5.10. Others
                        5.10.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Proteinase K: End Use Estimates & Trend Analysis
                    6.1. Proteinase K Market: Key Takeaways
                    6.2. Proteinase K Market: Movement & Market Share Analysis, 2022 & 2030
                    6.3. Isolation and Purification of Genomic DNA & RNA
                        6.3.1. Isolation and purification of genomic DNA & RNA market estimates and forecasts, 2018 to 2030 (USD Million)
                    6.4. In Situ Hybridization
                        6.4.1. In situ hybridization market estimates and forecasts, 2018 to 2030 (USD Million)
                    6.5. Mitochondria Isolation
                        6.5.1. Mitochondria isolation market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Proteinase K: Application Estimates & Trend Analysis
                    7.1. Proteinase K Market: Key Takeaways
                    7.2. Proteinase K Market: Movement & Market Share Analysis, 2022 & 2030
                    7.3. Contract Research Organization
                        7.3.1. Contract research organization market estimates and forecasts, 2018 to 2030 (USD Million)
                    7.4. Academic Institutes
                        7.4.1. Academic institutes market estimates and forecasts, 2018 to 2030 (USD Million)
                    7.5. Biotechnology Companies
                        7.5.1. Biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
                    7.6. Diagnostic Laboratories
                        7.6.1. Diagnostic laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Proteinase K Market: Regional Estimates & Trend Analysis
                    8.1. Regional Outlook
                    8.2. Proteinase K Market by Region: Key Takeaways
                    8.3. North America
                        8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        8.3.2. U.S.
                            8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        8.3.3. Canada
                            8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                    8.4. Europe
                        8.4.1. UK
                            8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        8.4.2. Germany
                            8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        8.4.3. France
                            8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        8.4.4. Italy
                            8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        8.4.5. Spain
                            8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        8.4.6. Denmark
                            8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        8.4.7. Sweden
                            8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        8.4.8. Norway
                            8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                    8.5. Asia Pacific
                        8.5.1. Japan
                            8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        8.5.2. China
                            8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        8.5.3. India
                            8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        8.5.4. Australia
                            8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        8.5.5. Thailand
                            8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        8.5.6. South Korea
                            8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                    8.6. Latin America
                        8.6.1. Brazil
                            8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        8.6.2. Mexico
                            8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        8.6.3. Argentina
                            8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                    8.7. MEA
                        8.7.1. South Africa
                            8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        8.7.2. Saudi Arabia
                            8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        8.7.3. UAE
                            8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        8.7.4. Kuwait
                            8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 9. Competitive Landscape
                    9.1. Recent Developments & Impact Analysis, By Key Market Participants
                    9.2. Market Participant Categorization
                        9.2.1. Merck KGaA
                            9.2.1.1. Company overview
                            9.2.1.2. Financial performance
                            9.2.1.3. Product benchmarking
                            9.2.1.4. Strategic initiatives
                        9.2.2. QIAGEN
                            9.2.2.1. Company overview
                            9.2.2.2. Financial performance
                            9.2.2.3. Product benchmarking
                            9.2.2.4. Strategic initiatives
                        9.2.3. Thermo Fisher Scientific, Inc.
                            9.2.3.1. Company overview
                            9.2.3.2. Financial performance
                            9.2.3.3. Product benchmarking
                            9.2.3.4. Strategic initiatives
                        9.2.4. F. Hoffmann-La Roche Ltd
                            9.2.4.1. Company overview
                            9.2.4.2. Financial performance
                            9.2.4.3. Product benchmarking
                            9.2.4.4. Strategic initiatives
                        9.2.5. Abcam plc.
                            9.2.5.1. Company overview
                            9.2.5.2. Financial performance
                            9.2.5.3. Product benchmarking
                            9.2.5.4. Strategic initiatives
                        9.2.6. Agilent Technologies, Inc.
                            9.2.6.1. Company overview
                            9.2.6.2. Financial performance
                            9.2.6.3. Product benchmarking
                            9.2.6.4. Strategic initiatives
                        9.2.7. Biocatalysts
                            9.2.7.1. Company overview
                            9.2.7.2. Financial performance
                            9.2.7.3. Product benchmarking
                            9.2.7.4. Strategic initiatives
                        9.2.8. Minerva Biolabs GmbH
                            9.2.8.1. Company overview
                            9.2.8.2. Financial performance
                            9.2.8.3. Product benchmarking
                            9.2.8.4. Strategic initiatives
                        9.2.9. Promega Corporation
                            9.2.9.1. Company overview
                            9.2.9.2. Financial performance
                            9.2.9.3. Product benchmarking
                            9.2.9.4. Strategic initiatives
                        9.2.10. Takara Bio Inc.
                            9.2.10.1. Company overview
                            9.2.10.2. Financial performance
                            9.2.10.3. Product benchmarking
                            9.2.10.4. Strategic initiatives
                        9.2.11. New England Biolabs
                            9.2.11.1. Company overview
                            9.2.11.2. Financial performance
                            9.2.11.3. Product benchmarking
                            9.2.11.4. Strategic initiatives
                        9.2.12. MP BIOMEDICALS.
                            9.2.12.1. Company overview
                            9.2.12.2. Financial performance
                            9.2.12.3. Product benchmarking
                            9.2.12.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America proteinase K market, by form, 2018 - 2030 (USD Million)
Table 3 North America proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 4 North America proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 5 North America proteinase K market, by application, 2018 - 2030 (USD Million)
Table 6 North America proteinase K market, by region, 2018 - 2030 (USD Million)
Table 7 U.S. proteinase K market, by form, 2018 - 2030 (USD Million)
Table 8 U.S. proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 9 U.S. proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 10 U.S. proteinase K market, by application, 2018 - 2030 (USD Million)
Table 11 Canada proteinase K market, by form, 2018 - 2030 (USD Million)
Table 12 Canada proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 13 Canada proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 14 Canada proteinase K market, by application, 2018 - 2030 (USD Million)
Table 15 Europe proteinase K market, by form, 2018 - 2030 (USD Million)
Table 16 Europe proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 17 Europe proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 18 Europe proteinase K market, by application, 2018 - 2030 (USD Million)
Table 19 Europe proteinase K market, by region, 2018 - 2030 (USD Million)
Table 20 UK proteinase K market, by form, 2018 - 2030 (USD Million)
Table 21 UK proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 22 UK proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 23 UK proteinase K market, by application, 2018 - 2030 (USD Million)
Table 24 Germany proteinase K market, by form, 2018 - 2030 (USD Million)
Table 25 Germany proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 26 Germany proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 27 Germany proteinase K market, by application, 2018 - 2030 (USD Million)
Table 28 France proteinase K market, by form, 2018 - 2030 (USD Million)
Table 29 France proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 30 France proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 31 France proteinase K market, by application, 2018 - 2030 (USD Million)
Table 32 Italy proteinase K market, by form, 2018 - 2030 (USD Million)
Table 33 Italy proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 34 Italy proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 35 Italy proteinase K market, by application, 2018 - 2030 (USD Million)
Table 36 Spain proteinase K market, by form, 2018 - 2030 (USD Million)
Table 37 Spain proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 38 Spain proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 39 Spain proteinase K market, by application, 2018 - 2030 (USD Million)
Table 40 Denmark proteinase K market, by form, 2018 - 2030 (USD Million)
Table 41 Denmark proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 42 Denmark proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 43 Denmark proteinase K market, by application, 2018 - 2030 (USD Million)
Table 44 Sweden proteinase K market, by form, 2018 - 2030 (USD Million)
Table 45 Sweden proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 46 Sweden proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 47 Sweden proteinase K market, by application, 2018 - 2030 (USD Million)
Table 48 Norway proteinase K market, by form, 2018 - 2030 (USD Million)
Table 49 Norway proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 50 Norway proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 51 Norway proteinase K market, by application, 2018 - 2030 (USD Million)
Table 52 Asia Pacific proteinase K market, by form, 2018 - 2030 (USD Million)
Table 53 Asia Pacific proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 54 Asia Pacific proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 55 Asia Pacific proteinase K market, by application, 2018 - 2030 (USD Million)
Table 56 Asia Pacific proteinase K market, by region, 2018 - 2030 (USD Million)
Table 57 Japan proteinase K market, by form, 2018 - 2030 (USD Million)
Table 58 Japan proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 59 Japan proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 60 Japan proteinase K market, by application, 2018 - 2030 (USD Million)
Table 61 China proteinase K market, by form, 2018 - 2030 (USD Million)
Table 62 China proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 63 China proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 64 China proteinase K market, by application, 2018 - 2030 (USD Million)
Table 65 India proteinase K market, by form, 2018 - 2030 (USD Million)
Table 66 India proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 67 India proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 68 India proteinase K market, by application, 2018 - 2030 (USD Million)
Table 69 Australia proteinase K market, by form, 2018 - 2030 (USD Million)
Table 70 Australia proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 71 Australia proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 72 Australia proteinase K market, by application, 2018 - 2030 (USD Million)
Table 73 Thailand proteinase K market, by form, 2018 - 2030 (USD Million)
Table 74 Thailand proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 75 Thailand proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 76 Thailand proteinase K market, by application, 2018 - 2030 (USD Million)
Table 77 South Korea proteinase K market, by form, 2018 - 2030 (USD Million)
Table 78 South Korea proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 79 South Korea proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 80 South Korea proteinase K market, by application, 2018 - 2030 (USD Million)
Table 81 Latin America proteinase K market, by form, 2018 - 2030 (USD Million)
Table 82 Latin America proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 83 Latin America proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 84 Latin America proteinase K market, by application, 2018 - 2030 (USD Million)
Table 85 Latin America proteinase K market, by region, 2018 - 2030 (USD Million)
Table 86 Brazil proteinase K market, by form, 2018 - 2030 (USD Million)
Table 87 Brazil proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 88 Brazil proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 89 Brazil proteinase K market, by application, 2018 - 2030 (USD Million)
Table 90 Mexico proteinase K market, by form, 2018 - 2030 (USD Million)
Table 91 Mexico proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 92 Mexico proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 93 Mexico proteinase K market, by application, 2018 - 2030 (USD Million)
Table 94 Argentina proteinase K market, by form, 2018 - 2030 (USD Million)
Table 95 Argentina proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 96 Argentina proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 97 Argentina proteinase K market, by application, 2018 - 2030 (USD Million)
Table 98 Middle East and Africa proteinase K market, by form, 2018 - 2030 (USD Million)
Table 99 Middle East and Africa proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 100 Middle East and Africa proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 101 Middle East and Africa proteinase K market, by application, 2018 - 2030 (USD Million)
Table 102 Middle East and Africa proteinase K market, by region, 2018 - 2030 (USD Million)
Table 103 South Africa proteinase K market, by form, 2018 - 2030 (USD Million)
Table 104 South Africa proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 105 South Africa proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 106 South Africa proteinase K market, by application, 2018 - 2030 (USD Million)
Table 107 Saudi Arabia proteinase K market, by form, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 110 Saudi Arabia proteinase K market, by application, 2018 - 2030 (USD Million)
Table 111 UAE proteinase K market, by form, 2018 - 2030 (USD Million)
Table 112 UAE proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 113 UAE proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 114 UAE proteinase K market, by application, 2018 - 2030 (USD Million)
Table 115 Kuwait proteinase K market, by form, 2018 - 2030 (USD Million)
Table 116 Kuwait proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 117 Kuwait proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 118 Kuwait proteinase K market, by application, 2018 - 2030 (USD Million) 

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Proteinase K: Market outlook
Fig. 9 Proteinase K: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Proteinase K market driver impact
Fig. 15 Proteinase K market restraint impact
Fig. 16 Proteinase K market strategic initiatives analysis
Fig. 17 Proteinase K market: Form movement analysis
Fig. 18 Proteinase K market: Form outlook and key takeaways
Fig. 19 Powder market estimates and forecasts, 2018 - 2030
Fig. 20 Liquid market estimates and forecasts, 2018 - 2030
Fig. 21 Proteinase K market: Therapeutic area movement analysis
Fig. 22 Proteinase K market: Therapeutic area outlook and key takeaways
Fig. 23 Infectious diseases market estimates and forecasts, 2018 - 2030
Fig. 24 Diabetes market estimates and forecasts, 2018 - 2030
Fig. 25 Oncology market estimates and forecasts, 2018 – 2030
Fig. 26 Cardiology market estimates and forecasts, 2018 - 2030
Fig. 27 Nephrology market estimates and forecasts, 2018 - 2030
Fig. 28 Autoimmune diseases market estimates and forecasts, 2018 - 2030
Fig. 29 Neurology market estimates and forecasts, 2018 - 2030
Fig. 30 Others market estimates and forecasts, 2018 - 2030
Fig. 31 Proteinase K market: Application movement analysis
Fig. 32 Proteinase K market: Application outlook and key takeaways
Fig. 33 Isolation and purification of genomic DNA & RNA market estimates and forecasts, 2018 - 2030
Fig. 34 In situ hybridization market estimates and forecasts, 2018 - 2030
Fig. 35 Mitochondria isolation market estimates and forecasts, 2018 – 2030
Fig. 36 Proteinase K market: End use movement analysis
Fig. 37 Proteinase K market: End use outlook and key takeaways
Fig. 38 Contract research organization market estimates and forecasts, 2018 - 2030
Fig. 39 Academic institutes market estimates and forecasts, 2018 - 2030
Fig. 40 Biotechnology companies market estimates and forecasts, 2018 - 2030
Fig. 41 Diagnostic laboratories market estimates and forecasts, 2018 - 2030
Fig. 42 Global proteinase K market: Regional movement analysis
Fig. 43 Global proteinase K market: Regional outlook and key takeaways
Fig. 44 North America market estimates and forecasts, 2018 - 2030
Fig. 45 U.S. market estimates and forecasts, 2018 - 2030
Fig. 46 Canada market estimates and forecasts, 2018 - 2030
Fig. 47 Europe market estimates and forecasts, 2018 - 2030
Fig. 48 UK market estimates and forecasts, 2018 - 2030
Fig. 49 Germany market estimates and forecasts, 2018 - 2030
Fig. 50 France market estimates and forecasts, 2018 - 2030
Fig. 51 Italy market estimates and forecasts, 2018 - 2030
Fig. 52 Spain market estimates and forecasts, 2018 - 2030
Fig. 53 Denmark market estimates and forecasts, 2018 - 2030
Fig. 54 Sweden market estimates and forecasts, 2018 - 2030
Fig. 55 Norway market estimates and forecasts, 2018 - 2030
Fig. 56 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 57 Japan market estimates and forecasts, 2018 - 2030
Fig. 58 China market estimates and forecasts, 2018 - 2030
Fig. 59 India market estimates and forecasts, 2018 - 2030
Fig. 60 Australia market estimates and forecasts, 2018 - 2030
Fig. 61 Thailand market estimates and forecasts, 2018 - 2030
Fig. 62 South Korea market estimates and forecasts, 2018 - 2030
Fig. 63 Latin America market estimates and forecasts, 2018 - 2030
Fig. 64 Brazil market estimates and forecasts, 2018 - 2030
Fig. 65 Mexico market estimates and forecasts, 2018 - 2030
Fig. 66 Argentina market estimates and forecasts, 2018 - 2030
Fig. 67 Middle East and Africa. market estimates and forecasts, 2018 - 2030
Fig. 68 South Africa market estimates and forecasts, 2018 - 2030
Fig. 69 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 70 UAE market estimates and forecasts, 2018 - 2030
Fig. 71 Kuwait market estimates and forecasts, 2018 - 2030